journal article·2018-02-14

Degradable NIR-PTT Nanoagents with a Potential Cu@Cu2O@Polymer Structure

Yu-Wei Tai, Yi-Chun Chiu, Po-Ting Wu, Jiashing Yu, Yu-Cheng Chin, Shu-Pao Wu, Yu-Chun Chuang, Ho-Chen Hsieh, Ping-Shan Lai, Hsiu-Ping Yu, Mei-Yi Liao

Publisher page

Abstract

Cu@Cu 2 O@PSMA polymer nanoparticles (Cu@Cu 2 O@polymer NPs) with near-infrared (NIR) absorption were successfully synthesized in a single-step oxidation reaction of Cu@PSMA polymer NPs at 100 °C for 20 min. The shape, structure, and optical properties of the Cu@Cu 2 O@polymer NPs were tailorable by controlling the reaction parameters, for example, using the initial Cu@PSMA polymer NP as a template and varying the halide ion content, heating temperature, and reaction time. The Cu@Cu 2 O@polymer NPs exhibited robust NIR absorption between 650 and 710 nm and possessed superior oxidation resistance in water and culture media. In vitro assays demonstrated the low cytotoxicity of the Cu@Cu 2 O@PSMA polymer NPs to HeLa cells through an improved cell viability, high IC 50, low injury incidence from the supernatant of the partly dissociated Cu@Cu 2 O@PSMA polymer NPs, and minor generation of reactive oxygen species. More importantly, we demonstrated that the inorganic Cu-based nanocomposite [+0.34 V vs normal hydrogen electrode (NHE)] was degradable in an endogenous H 2 O 2 (+1.78 V vs NHE) environment. Cu ions were detected in the urine of mice, which illustrates the possibility of extraction after the degradation of the Cu-based particles. 'After an treatment of the HeLa cells with the Cu@Cu 2 O@polymer NPs and a 660 nm light-emitting diode, the photoablation of 50 and 90% cells was observed at NP doses of 20 and 50 ppm, respectively. These results demonstrate that NIR-functional and moderate redox-active Cu@Cu 2 O@polymer NPs are potential next-generation photothermal therapy (PTT) nanoagents because of combined features of degradation resistance in the physiological environment, enabling the delivery of efficient PTT, a possibly improved ability to selectively harm cancer cells by releasing Cu ions under high-H 2 O 2 and/or low-pH conditions, and ability to be extracted from the body after biodegradation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, National Taiwan University, Taipei 106, Taiwan

Division of Urology, Department of Surgery, Zhongxiao Branch, Taipei City Hospital, Taipei 11556, Taiwan

Department of Applied Chemistry, National Pingtung University, Pingtung 90003, Taiwan

Department of Applied Chemistry, National Chiao Tung University, Hsinchu 300, Taiwan

National Synchrotron Radiation Research Center, Hsinchu 300, Taiwan

Department of Chemistry, National Chung Hsing University, Taichung 402, Taiwan

Funding

Ministry of Science and Technology, Taiwan · Department of Health, Taipei City Government · Taipei City Hospital

References (67)

Show source-provided references
1. 10.1038/am.2016.10610.1038/am.2016.106 ↗
2. 10.1021/acs.chemrev.5b0048210.1021/acs.chemrev.5b00482 ↗
3. 10.1039/c5nr03157e10.1039/c5nr03157e ↗
4. 10.1021/nn402201w10.1021/nn402201w ↗
5. 10.1002/smll.20120139010.1002/smll.201201390 ↗
6. 10.1146/annurev-bioeng-071811-15012410.1146/annurev-bioeng-071811-150124 ↗
7. 10.1016/j.pmatsci.2017.03.00410.1016/j.pmatsci.2017.03.004 ↗
8. 10.1002/adma.20080139310.1002/adma.200801393 ↗
9. 10.1002/adfm.20120038210.1002/adfm.201200382 ↗
10. 10.1002/adfm.20050089810.1002/adfm.200500898 ↗
11. 10.1021/jp505979e10.1021/jp505979e ↗
12. 10.1021/am506429810.1021/am5064298 ↗
13. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
14. 10.1002/anie.20130898610.1002/anie.201308986 ↗
15. 10.1021/acsnano.6b0626710.1021/acsnano.6b06267 ↗
16. 10.1016/j.biomaterials.2012.06.06210.1016/j.biomaterials.2012.06.062 ↗
17. 10.1002/smll.20140324910.1002/smll.201403249 ↗
18. 10.1021/acs.chemmater.6b0373810.1021/acs.chemmater.6b03738 ↗
19. 10.1021/acsami.6b0994210.1021/acsami.6b09942 ↗
20. 10.1021/acsnano.6b0595110.1021/acsnano.6b05951 ↗
21. 10.1088/0957-4484/19/25/25510210.1088/0957-4484/19/25/255102 ↗
22. 10.1021/acsami.6b0572710.1021/acsami.6b05727 ↗
23. 10.1021/es504918q10.1021/es504918q ↗
24. 10.1002/wnan.10310.1002/wnan.103 ↗
25. 10.1039/c2jm35041f10.1039/c2jm35041f ↗
26. 10.1021/cm403098d10.1021/cm403098d ↗
27. 10.1021/acsami.5b0756610.1021/acsami.5b07566 ↗
28. 10.1088/1361-6528/aa57b010.1088/1361-6528/aa57b0 ↗
29. 10.1039/c5tb00567a10.1039/c5tb00567a ↗
30. 10.1021/acsami.6b0954210.1021/acsami.6b09542 ↗
31. 10.1186/1743-8977-6-1410.1186/1743-8977-6-14 ↗
32. 10.1016/j.toxlet.2005.10.00310.1016/j.toxlet.2005.10.003 ↗
33. 10.1038/cddis.2013.31410.1038/cddis.2013.314 ↗
34. 10.1073/pnas.95.14.787210.1073/pnas.95.14.7872 ↗
35. 10.1038/srep0232310.1038/srep02323 ↗
36. 10.1021/acs.chemmater.6b0037710.1021/acs.chemmater.6b00377 ↗
37. 10.1021/la048255410.1021/la0482554 ↗
38. 10.1021/cm202078t10.1021/cm202078t ↗
39. 10.1021/acs.jpcc.6b0013710.1021/acs.jpcc.6b00137 ↗
40. 10.1021/jp211565c10.1021/jp211565c ↗
41. 10.1021/nn300546w10.1021/nn300546w ↗
42. 10.1039/c2jm14963j10.1039/c2jm14963j ↗
43. 10.1021/jp110483z10.1021/jp110483z ↗
44. 10.1016/j.freeradbiomed.2008.05.00410.1016/j.freeradbiomed.2008.05.004 ↗
45. 10.1016/j.canlet.2006.10.02910.1016/j.canlet.2006.10.029 ↗
46. Tannock I. F. · Cancer Res. · 1989 · 49 · 4373
47. 10.1021/acscentsci.6b0019710.1021/acscentsci.6b00197 ↗
48. 10.1002/adma.20130236310.1002/adma.201302363 ↗
49. 10.1021/ja067785e10.1021/ja067785e ↗
50. 10.1016/j.nantod.2008.10.00910.1016/j.nantod.2008.10.009 ↗
51. 10.1038/srep0559310.1038/srep05593 ↗
52. 10.1021/acsami.5b0711010.1021/acsami.5b07110 ↗
53. 10.1039/c4nr00193a10.1039/c4nr00193a ↗
54. 10.1016/j.physb.2011.03.08210.1016/j.physb.2011.03.082 ↗
55. 10.1039/c7nj03056h10.1039/c7nj03056h ↗
56. 10.1002/ppsc.20140015510.1002/ppsc.201400155 ↗
57. 10.3762/bjnano.6.13910.3762/bjnano.6.139 ↗
58. 10.1039/c4nr02025a10.1039/c4nr02025a ↗
59. 10.1126/science.109656610.1126/science.1096566 ↗
60. 10.1016/j.snb.2015.12.04410.1016/j.snb.2015.12.044 ↗
61. 10.1039/c2cc31448g10.1039/c2cc31448g ↗
62. 10.1016/j.colsurfb.2016.01.05210.1016/j.colsurfb.2016.01.052 ↗
63. 10.1021/nn300445d10.1021/nn300445d ↗
64. 10.1021/cr960421s10.1021/cr960421s ↗
65. 10.1007/s11243-012-9583-610.1007/s11243-012-9583-6 ↗
66. 10.1002/hep.2125410.1002/hep.21254 ↗
67. 10.1007/s10895-011-0955-710.1007/s10895-011-0955-7 ↗